Ithaca, NY, United States of America

Richard Yeh




Average Co-Inventor Count = 5.6

ph-index = 3

Forward Citations = 114(Granted Patents)


Company Filing History:


Years Active: 2006-2011

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Richard Yeh

Introduction

Richard Yeh, an accomplished inventor based in Ithaca, NY, has significantly contributed to the field of biomedicine with a focus on IL-17 receptor-like molecules. With a total of five patents to his name, Yeh's work has the potential to revolutionize treatments for various diseases by leveraging the power of innovative polypeptides.

Latest Patents

Among his latest inventions, Yeh has developed a patent titled "IL-17 receptor-like molecules and uses thereof." This invention introduces IL-17 receptor-like polypeptides and corresponding nucleic acid molecules, paving the way for the creation of vectors, host cells, agonists, and antagonists. Additionally, the methods articulated in this patent facilitate the production of IL-17 receptor-like polypeptides that could be instrumental in diagnosing, treating, and even preventing diseases.

Career Highlights

Yeh's association with Amgen Inc. marks a significant milestone in his career. At Amgen, he has been actively engaged in advancing research and innovation related to biopharmaceuticals, further cementing his status as a key player in the field of medical technology.

Collaborations

Throughout his career, Richard Yeh has collaborated with various noteworthy individuals, including Scott Michael Silbiger and Eugene Medlock. These collaborations have played an essential role in amplifying his innovative contributions and expanding his intellectual footprint within the scientific community.

Conclusion

In conclusion, Richard Yeh's inventive prowess and collaborative spirit at Amgen Inc. underscore his vital role in the advancement of biomedicine. His patents on IL-17 receptor-like molecules not only enhance our understanding of polypeptides but also hold promise for significant therapeutic applications in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…